Cross-reactive antibody immunity against SARS-CoV-2 in children and adults.

Creator(s)

Elizabeth Fraley, Children's Mercy HospitalFollow
Cas LeMaster, Children's Mercy HospitalFollow
Dithi Banerjee, Children's Mercy HospitalFollow
Santosh Khanal, Children's Mercy HospitalFollow
Rangaraj Selvarangan, Children's Mercy HospitalFollow
Todd Bradley, Children's Mercy HospitalFollow

Document Type

Letter to the Editor

Publication Date

7-2021

Identifier

DOI: 10.1038/s41423-021-00700-0; PMCID: PMC8165340

Journal Title

Cell Mol Immunol

Volume

18

Issue

7

First Page

1826

Last Page

1828

MeSH Keywords

Adolescent; Adult; Age Factors; Aged; Antibodies, Viral; Antibody Specificity; Biomarkers; COVID-19; COVID-19 Serological Testing; Case-Control Studies; Child; Child, Preschool; Coronavirus Nucleocapsid Proteins; Cross Reactions; Epitope Mapping; Epitopes; Female; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Male; Middle Aged; Phosphoproteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Young Adult

Keywords

Adolescent; Adult; Age Factors; Aged; Antibodies, Viral; Antibody Specificity; Biomarkers; COVID-19; COVID-19 Serological Testing; Case-Control Studies; Child; Child, Preschool; Coronavirus Nucleocapsid Proteins; Cross Reactions; Epitope Mapping; Epitopes; Female; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Male; Middle Aged; Phosphoproteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Young Adult

Recommended Citation

Fraley E, LeMaster C, Banerjee D, Khanal S, Selvarangan R, Bradley T. Cross-reactive antibody immunity against SARS-CoV-2 in children and adults. Cell Mol Immunol. 2021;18(7):1826-1828. doi:10.1038/s41423-021-00700-0